|1.||Forsayeth, John: 4 articles (04/2012 - 02/2006)|
|2.||Bankiewicz, Krystof S: 4 articles (04/2012 - 10/2006)|
|3.||Bankiewicz, K S: 4 articles (11/2009 - 07/2000)|
|4.||Cunningham, Janet: 4 articles (10/2006 - 08/2005)|
|5.||Bringas, John: 3 articles (02/2012 - 02/2006)|
|6.||Eberling, J L: 3 articles (11/2009 - 07/2000)|
|7.||Sanftner, Laura M: 3 articles (10/2006 - 08/2005)|
|8.||Forsayeth, John R: 3 articles (10/2006 - 08/2005)|
|9.||Zhang, Mengliang: 2 articles (01/2015 - 09/2014)|
|10.||Wienecke, Jacob: 2 articles (01/2015 - 09/2014)|
|1.||Parkinson Disease (Parkinson's Disease)
04/01/2012 - "We report the results of a long-term follow-up of subjects in a phase 1 study of AAV2-hAADC (adeno-associated virus type 2-human aromatic L-amino acid decarboxylase) gene therapy for the treatment of Parkinson's disease (PD). "
11/01/2010 - "Qualitative imaging of adeno-associated virus serotype 2-human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease."
09/01/2010 - "A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson's disease."
08/01/2005 - "AAV2 encoding the human aromatic l-amino acid decarboxylase gene (AAV-hAADC-2) was infused into the putamen of 4 normal rhesus monkeys as a supportive study for a clinical trial in Parkinson's disease (PD) patients. "
11/01/2010 - "Putaminal convection-enhanced delivery (CED) of an adeno-associated virus serotype 2 (AAV2) vector, containing the human aromatic L-amino acid decarboxylase (hAADC) gene for the treatment of Parkinson disease (PD), has completed a phase I clinical trial. "
|2.||Small Cell Lung Carcinoma (Small Cell Lung Cancer)
09/01/1986 - "Immunohistochemical study of small cell lung carcinoma; with special reference to the neuroendocrine markers aromatic L-amino acid decarboxylase and gastrin-releasing peptide."
11/01/2000 - "The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells."
04/15/2005 - "alpha-Methyl-dopahydrazine (carbidopa), an inhibitor of the serotonin synthetic enzyme aromatic-L-amino acid decarboxylase, proved lethal to NCI-H727 lung carcinoid cells as well as NCI-H146 and NCI-H209 SCLC cells, but not to five other human tumor cell lines of differing origins [Gilbert JA, Frederick LM, Ames MM. The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells. "
08/01/1998 - "Undifferentiated small cell lung carcinoma (SCLC) cell lines NCI-H82 and NCI-H526 were treated with TNF-alpha for up to 2 wk. Both cell lines demonstrated rapid induction of gastrin-releasing peptide (GRP) mRNA; H82 cells also expressed aromatic-L-amino acid decarboxylase mRNA within 5 min after TNF-alpha was added. "
|3.||Schizophrenia (Dementia Praecox)
05/01/2000 - "Comparative sequencing and association studies of aromatic L-amino acid decarboxylase in schizophrenia and bipolar disorder."
10/03/1997 - "Does phenylethylamine have a role in schizophrenia?: LSD and PCP up-regulate aromatic L-amino acid decarboxylase mRNA levels."
01/01/1994 - "Quantification of mRNA of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in the substantia nigra in Parkinson's disease and schizophrenia."
03/01/2014 - "Electroacupuncture at the sciatic nerve controls systemic inflammation by inducing vagal activation of aromatic L-amino acid decarboxylase, leading to the production of dopamine in the adrenal medulla. "
04/01/2004 - "The present study aimed to evaluate the relationship between intestinal inflammation, interferon-gamma (IFN-gamma) levels and intestinal levels of dopamine, its precursor l-3,4-dihydroxyphenylalanine (L-DOPA), and the activity of aromatic L-amino acid decarboxylase (AADC) activity along the digestive tract in a rat experimental model of colitis. "
|5.||Melanoma (Melanoma, Malignant)
|1.||Levodopa (L Dopa)
|3.||Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)
|5.||GTP Cyclohydrolase (GTP Cyclohydrolase I)
|8.||Glutamic Acid (Glutamate)
|9.||Glutamate Receptors (Glutamate Receptor)
|10.||S100 Proteins (S 100 Protein)